AbstractThis article is part of a series of manuscripts dealing with the incorporation of patient-reported outcomes (PROs) into clinical trials. The issues dealt with in this manuscript concern the common pitfalls to avoid in statistical analysis and interpretation of PROs. Specifically, the questions addressed by this manuscript involve the analysis pitfalls with PRO data in clinical trials and how can they be avoided (e.g.,missing data, multiplicity, null results etc.). The manuscript provides key literature for existing resources and proposes new guidelines
Patient-reported outcomes (PROs) are increasingly used in single-arm cancer studies. We reviewed 60 ...
Methodological issues may limit the impact and application of patient-reported outcome (PRO) evidenc...
Missing data is a potential source of bias in the results of randomised controlled trials (RCTs), wh...
ABSTRACT This article is part of a series of manuscripts dealing with the incorporation of patient-r...
AbstractThis article is part of a series of manuscripts dealing with the incorporation of patient-re...
ABSTRACT This article deals with the incorporation of patient-reported outcomes (PROs) into clinical...
AbstractThis article deals with the incorporation of patient-reported outcomes (PROs) into clinical ...
AbstractPatient-reported outcomes (PROs) can be included in clinical trials as primary or secondary ...
AbstractThis article concerns development and use of patient-reported outcomes (PROs) in clinical tr...
AbstractPatient-reported outcomes (PROs) have become increasingly prevalent in clinical research and...
BACKGROUND Patient-reported outcomes (PROs) are commonly collected in clinical trials and should ...
BACKGROUND: Patient reported outcomes (PROs) are increasingly assessed in clinical trials, and guide...
<div><p>Background</p><p>Patient reported outcomes (PROs) are increasingly assessed in clinical tria...
There is substantial and growing interest in measuring patient-reported outcomes in drug development...
Background: Patient reported outcomes (PROs) are increasingly assessed in clinical trials, and guide...
Patient-reported outcomes (PROs) are increasingly used in single-arm cancer studies. We reviewed 60 ...
Methodological issues may limit the impact and application of patient-reported outcome (PRO) evidenc...
Missing data is a potential source of bias in the results of randomised controlled trials (RCTs), wh...
ABSTRACT This article is part of a series of manuscripts dealing with the incorporation of patient-r...
AbstractThis article is part of a series of manuscripts dealing with the incorporation of patient-re...
ABSTRACT This article deals with the incorporation of patient-reported outcomes (PROs) into clinical...
AbstractThis article deals with the incorporation of patient-reported outcomes (PROs) into clinical ...
AbstractPatient-reported outcomes (PROs) can be included in clinical trials as primary or secondary ...
AbstractThis article concerns development and use of patient-reported outcomes (PROs) in clinical tr...
AbstractPatient-reported outcomes (PROs) have become increasingly prevalent in clinical research and...
BACKGROUND Patient-reported outcomes (PROs) are commonly collected in clinical trials and should ...
BACKGROUND: Patient reported outcomes (PROs) are increasingly assessed in clinical trials, and guide...
<div><p>Background</p><p>Patient reported outcomes (PROs) are increasingly assessed in clinical tria...
There is substantial and growing interest in measuring patient-reported outcomes in drug development...
Background: Patient reported outcomes (PROs) are increasingly assessed in clinical trials, and guide...
Patient-reported outcomes (PROs) are increasingly used in single-arm cancer studies. We reviewed 60 ...
Methodological issues may limit the impact and application of patient-reported outcome (PRO) evidenc...
Missing data is a potential source of bias in the results of randomised controlled trials (RCTs), wh...